News A milestone in insulin automation, Medtronic's MiniMed 670G ... The MiniMed 670G has launched in the US, following FDA approval last year.
Views & Analysis ADA preview: cardio data in diabetes, drug costs and healthc... Invokana data could suggest cardio benefit for SGLT2 class.
Views & Analysis Novo Nordisk: survival of the fittest applies in diabetes an... Diabetes specialist Novo Nordisk is feeling the heat from increasingly price conscious US payers.
News Glooko and Dexcom expand diabetes deal Deal will let patients access diabetes data in real-time.
News Novo hopes hypoglycaemia data will boost Tresiba Lower severe hypo risk compared with Lantus - but no cardiac benefit.
News Senseonics raises funds for Eversense continuous glucose mon... Money will aid in impending US launch.
News NICE backs AZ/Ionis' Wainzua for ATTR polyneuropathy AstraZeneca and Ionis' Wainzua has been recommended for NHS use in the treatment of patients with ATTR polyneuropathy
Sales & Marketing Coming soon: The Life Sciences Industry Report 2025 – insigh... Prepare for 2025 with pharmaphorum’s Life Sciences Report, featuring expert insights on AI in drug development, gene therapy, and top industry trends
